16 results
8-K
EX-1.1
DRMA
Dermata Therapeutics Inc
7 Jun 24
Entry into a Material Definitive Agreement
5:11pm
to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation … with Privacy Laws. (i) The Company and the Subsidiaries are, and at all times during the past three years were, in material compliance with all
8-K
EX-10.1
DRMA
Dermata Therapeutics Inc
24 May 23
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized
424B4
DRMA
Dermata Therapeutics Inc
13 May 22
Prospectus supplement with pricing info
5:06pm
, maintain or transmit individually identifiable health information for or on behalf of a covered entity, with respect to safeguarding the privacy, security … governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may
8-K
EX-10.1
prjj3 f4y8bvdlmik3
25 Apr 22
Dermata Therapeutics Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
4:45pm
10-K
awo4tw8ve mk
28 Mar 22
Annual report
8:33am
DRS
d9xf2h0dux6j8
11 Jan 22
Draft registration statement
12:00am
424B4
880ckmhcu8oaoqkb7zss
16 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1
23x92z 916wpzev4
10 Jun 21
IPO registration
5:11pm
DRS/A
pt8xjadbe5 xo
7 May 21
Draft registration statement (amended)
12:00am
DRS
5qr6yoo
2 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next